Biofrontera Inc. Prepaid Expense, Current
Biofrontera Inc. (BFRI) had Prepaid Expense, Current of $305.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Balance Sheet › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2024-03-15
- 2023-12-31: Prepaid Expense, Current $305.00K.
- 2022-12-31: Prepaid Expense, Current $439.00K.
- 2022-09-30: Prepaid Expense, Current $460.00K.
- 2022-06-30: Prepaid Expense, Current $599.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2023-12-31 | $305.00K 10-K · filed 2024-03-15 |
| 2022-12-31 | $439.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $460.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $599.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $723.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $824.00K 8-K · filed 2023-10-03 |
| 2021-09-30 | $390.00K 10-Q · filed 2021-11-30 |
| 2020-12-31 | $497.00K 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |